When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Sumatriptan - Wikipedia

   en.wikipedia.org/wiki/Sumatriptan

   Sumatriptan, sold under the brand name Imitrex among others, is a medication used to treat migraine headaches and cluster headaches. [1] It is taken orally, intranasally, or by subcutaneous injection. [2] Therapeutic effects generally occur within three hours. [2]

3. Naratriptan - Wikipedia

   en.wikipedia.org/wiki/Naratriptan

   Naratriptan (trade names include Amerge) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. It is a selective 5-HT 1 receptor subtype agonist . It was patented in 1987 and approved for medical use in 1997.

4. Management of migraine - Wikipedia

   en.wikipedia.org/wiki/Management_of_migraine

   Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...

5. Antimigraine drug - Wikipedia

   en.wikipedia.org/wiki/Antimigraine_drug

   Opioids are not recommended for treatment of acute migraines due to their significant side effect profile, including twice the risk of medication overuse headache when compared to NSAIDS, acetaminophen or triptans. [3] In addition, their strength of efficacy has showed to be low or insufficient for pain relief of migraines. [3]

6. Eletriptan - Wikipedia

   en.wikipedia.org/wiki/Eletriptan

   Eletriptan was approved by the US Food and Drug Administration (FDA) in December 2002, for the acute treatment of migraine with or without aura in adults. [5] It is available only by prescription in the United States, Canada and Australia. It is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or ...

7. Eptinezumab - Wikipedia

   en.wikipedia.org/wiki/Eptinezumab

   The US Food and Drug Administration (FDA) approved eptinezumab based primarily on evidence from two clinical trials (Trial 1/NCT02559895 and Trial 2/NCT02974153) of 1741 participants with chronic or episodic migraine headaches. [10] Trials were conducted at 212 sites in United States, Georgia, Russia, Ukraine and the European Union. [10]